Dr. Steven Kenneth Roelofs Audiologist Medicare: Medicare Enrolled Practice Location: 502 Willamette St, Oregon City, OR 97045 Phone: 541-285-3322 |
Mr. Gary E Mcclellan, MA IN AUDIOLOGY Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1508 Division St, #115 Gary E Mcclellan Ma, Oregon City, OR 97045 Phone: 503-656-0601 Fax: 503-656-1389 |
Willamette Falls Audiology, Inc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1508 Division St, 115, Oregon City, OR 97045 Phone: 503-656-0601 |
Ms. Sarah Nmi Echternkamp, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1508 Division St, Oregon City, Oregon City, OR 97045 Phone: 503-656-0601 Fax: 503-656-1389 |
Luna Family Hearing Audiologist Medicare: Not Enrolled in Medicare Practice Location: 19142 S Molalla Ave, Oregon City, OR 97045 Phone: 503-518-3300 Fax: 503-518-3301 |
News Archive
In Kenya, "[i]ntravenous drug users (IDUs) have been largely ignored by the government's HIV programmes on the basis that drug-taking is illegal, but a new policy is being drafted with the aim of reducing HIV transmission among this high-risk group," IRIN/PlusNews reports. The article includes comments from Nicholas Muraguri, head of the National AIDS and Sexually Transmitted Infections Control Programme, who said that the policy would treat drug use as a health issue, not a criminal one.
Life Technologies Corporation today announced it has completed and settled the previously announced offering of $250 million aggregate principal amount of 3.375% Senior Notes due 2013 at an issue price of 99.953 percent; $500 million aggregate principal amount of 4.400% Senior Notes due 2015 at an issue price of 99.668 percent; and $750 million aggregate principal amount of 6.000% Senior Notes due 2020 at an issue price of 99.796 percent. The notes will pay interest on a semi-annual basis.
Researchers at the University of Minnesota have shown that increasing the concentration of a key regulator involved in glucose metabolism can improve the way the liver produces and disposes of the sugar glucose, the primary fuel of the body. Finding ways to increase that concentration could provide a treatment for diabetes and obesity.
CardioFocus, Inc., developer of the HeartLight Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announces its technology is now available in the Netherlands. Physicians at Isala Klinieken in Zwolle were the first in the country to incorporate visually guided ablation into their regular therapeutic practice and have successfully treated several patients.
The nascent European seed brachytherapy market has been grappling with issues of high procedural and investment costs and a lack of local clinical evidence. However, growing evidence of the overall clinical and cost benefits of seed brachytherapy coupled with rising patient awareness is set to boost market expansion.
› Verified 3 days ago